Alexion has been operating in France since and works to provide optimal care for patients affected by a rare disease. In France, we work across various rare diseases and devastating conditions, including:.
A rare disease that can cause progressive injury to vital organs, primarily the kidneys, via damage to the walls of blood vessels and blood clots. A rare, progressive, genetic condition characterised by non-malignant non-cancerous tumors called plexiform neurofibromas PN that develop in the brain, and along the spinal cord and nerve.
A rare, autoimmune neuromuscular disease characterised by loss of muscle function and severe muscle weakness. A rare autoimmune disease of the central nervous system, characterised by unpredictable relapses which can result in cumulative disability. This can lead to poor growth and development, weakness and deformity of bones and other skeletal abnormalities, and premature loss of teeth with the root intact.
A genetic, and progressive ultra-rare metabolic disease associated with multiorgan damage in infant, paediatric and adult patients, and premature death in infants.
Our medicines available in France:. Alexion is committed to serving people affected by rare diseases through the discovery, development and access of life-changing medicines.
